Skip to main content
. 2016 May 23;16(6):e34432. doi: 10.5812/hepatmon.34432

Table 2. Demography of the Patientsa.

Group HD AC ACH Cir HCC
Age (y) Means (minimal - maximal) 37 (27 - 55) 31 (23 - 51) 40 (20 - 50) 41 (28 - 56) 49 (37 - 67)
F/M 1/5 1/5 0/6 0/6 1/5
HBsAg (0 - 1.0 S/CO) Neg 200.74 ± 141.17 75.14 ± 76.12 98.50 ± 44.08 112.01 ± 60.35
HBeAg (0 - 0.28 PEIU/ml) Neg 1433 ± 1483.40 186.88 ± 218.20 76.88 ± 152.49 11.99 ± 16.66
HBV-DNA < 2.70 copies/ml (log) Neg 7.88 ± 1.32 5.00 ± 20.4 5.34 ± 1.07 5.81±1.25
TB (5.1 - 19 µmol/L) Nor 16.47 ± 3.73 107.80 ± 88.93 56.97 ± 29.05 17.77 ± 7.98
DB (1.7 - 6.8 µmol/L) Nor 6.15 ± 1.11 44.25 ± 37.81 24.35 ± 15.38 6.97 ± 1.97
ALT (5 - 40 u/L) Nor 32.53 ± 5.93 793.03 ± 1452.55 86.32 ± 59.52 55.78 ± 24.66
Necroinflammation score(N 0 - 18) 0.5 ± 0.55 0.67 ± 0.47 14.83 ± 2.85 7.67 ± 1.25 3.5 ± 1.12
Fibrosis score (F 0 - 6) 0 0 1.5 ± 0.5 6 ± 0 1.17 ± 0.68

aThe lesions of necroinflammation and fibrosis were graded according to the Ishak Modified HAI. The maximum possible scores for necroinflammation and fibrosis were 18 and 6, respectively.